Page last updated: 2024-08-25

dexrazoxane and Diffuse Mixed Small and Large Cell Lymphoma

dexrazoxane has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brion, A; Cahn, JY; Daguindau, E; Deconinck, E; Limat, S; Nerich, V; Perrin, S; Woronoff-Lemsi, MC1

Other Studies

1 other study(ies) available for dexrazoxane and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
    Journal of clinical pharmacy and therapeutics, 2014, Volume: 39, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cardiotonic Agents; Cyclophosphamide; Dexrazoxane; Doxorubicin; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Vincristine; Young Adult

2014